Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

NCT06064071 is registered in ClinicalTrials.gov with Candela Corporation as lead sponsor.

NCT NCT06064071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06064071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
Lead sponsor
Candela Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 18, 2023
Completion date
September 30, 2025
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, meibomian gland dysfunction